Characteristics of Kappa-Opioid Receptors
Kappa-opioid receptors play an important role in regulating pain sensitivity. Their natural endogenous ligands are dynorphins. The primary anatomical localization of their effect is concentrated at the spinal cord level, which mediates spinal analgesia. Unlike mu-receptors, which are characterized by euphoria, activation of kappa-receptors causes specific psychotropic features—dysphoria, expressed as a negative emotional state and discomfort. In addition, the risk of developing physical dependence remains.
Pharmacological Effects
The pharmacological action upon stimulation of these receptors affects several body systems:
- Inhibition of pain impulse transmission due to spinal localization.
- Sedative effect, reducing overall activity.
- Miosis, i.e., pronounced pupil constriction.
- Minor decrease in gastrointestinal (GI) motility.
Molecular Mechanism and Signal Transduction
The interaction of opioids with the receptor apparatus occurs via G-proteins, triggering a sequential cascade of intracellular changes:
- Inhibition of the enzyme adenylate cyclase, leading to a decrease in the intracellular concentration of cAMP.
- Postsynaptic effect: opening of G-protein-coupled potassium channels. The outward efflux of $K^+$ ions causes hyperpolarization of the cell membrane and a drop in neuronal excitability.
- Presynaptic effect: blockade of N-type calcium channels. This limits the influx of $Ca^{2+}$ ions into the presynaptic terminal and disrupts neurotransmitter release into the synaptic cleft.